Impact of prophylactic cranial irradiation on pattern of brain metastases as a first recurrence site for limited-disease small-cell lung cancer.

J Radiat Res 2018 Nov;59(6):767-773

Division of Radiation Oncology and Particle therapy, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan.

This study sought to evaluate the impact of prophylactic cranial irradiation (PCI) on the pattern of brain recurrence after radical treatment in patients with limited-disease small-cell lung cancer (LD-SCLC). Patients treated with radiotherapy and chemotherapy between January 2006 and December 2014 at a single institution were retrospectively examined. Radiotherapy was performed using accelerated hyperfractionated radiotherapy (twice daily, 45 Gy in 30 fractions) or conventional fractionated radiotherapy (once daily, 50 Gy in 25 fractions). The chemotherapy regimen consisted of intravenous platinum-etoposide. A total of 162 patients were included and the median follow-up duration was 38 months. Ninety-three patients underwent PCI, and the 3-year overall survival (OS) rates were 14% among patients without PCI and 41% among those with PCI (P < 0.001). The frequency of brain metastases as a first recurrence site (BMFR) was significantly lower among patients who underwent PCI, compared with those who did not (P = 0.002). The median time to the l of BMFR was significantly shorter among patients without PCI than among those with PCI (P = 0.012). In addition, 68% of the BMFR patients who did not undergo PCI exhibited five or more lesions, while only 12% of BMFR patients who did undergo PCI exhibited five or more lesions (P < 0.001). PCI had a significant positive impact on patient prognosis after radical treatment for LD-SCLC, and the difference in the number of, and time to the appearance of, BMFR between patients treated with PCI and those treated without PCI might affect the clinical outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jrr/rry066DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251427PMC
November 2018
17 Reads

Publication Analysis

Top Keywords

bmfr patients
12
pci
12
patients
10
exhibited lesions
8
radiotherapy daily
8
recurrence site
8
limited-disease small-cell
8
small-cell lung
8
patients underwent
8
radical treatment
8
lung cancer
8
patients pci
8
underwent pci
8
metastases recurrence
8
cranial irradiation
8
undergo pci
8
impact prophylactic
8
prophylactic cranial
8
patients treated
8
pci exhibited
8

References

(Supplied by CrossRef)
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results database
Govindan et al.
J Clin Oncol 2006
Small-cell lung cancer
Jackman et al.
Lancet 2005
Neurologic disorders in 432 consecutive patients with small cell lung carcinoma
Seute et al.
Cancer 2004
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis
Meert et al.
BMC Cancer 2001
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group
Auperin et al.
N Engl J Med 1999
Prophylactic cranial irradiation for patients with small-cell lung cancer: a systematic review of the literature with meta-analysis
Zhang et al.
BMC Cancer 2014

National Comprehensive Cancer Network et al.
Prophylactic cranial irradiation for patients with limited-stage small-cell lung cancer with response to chemoradiation
Tai et al.
Clin Lung Cancer 2013
Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99–01, EORTC 22003–08004, RTOG 0212 and IFCT 99–01)
Le Pechoux et al.
Ann Oncol 2011
Prophylactic cranial irradiation in patients with small cell lung cancer. a retrospective study of recurrence, survival and morbidity
Ramlov et al.
Lung Cancer 2012
Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients
Arriagada et al.
Ann Oncol 2002

Similar Publications